INmune Bio, Inc. (INMB) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -3.4M | -2.96M | -5.44M | -7.38M | -6.82M | -11.01M | -6.99M | -7.89M | -7.48M | -3.4M | -4.26M | -3.17M | -1.14M | -5.7M | -3.37M | -4.76M | -8.87M | -9.78M | -7.92M | -5.71M |
| Operating CF Margin % | - | - | - | - | -13648% | - | - | - | -53400% | -12146.43% | -9916.28% | -6900% | -3002.63% | -5871.13% | -3435.71% | -29743.75% | -5438.65% | -6000% | -56592.86% | - |
| Operating CF Growth % | 50.13% | 73.17% | 22.14% | 6.48% | 8.72% | -223.82% | -63.84% | -148.46% | -555.21% | 40.28% | -26.64% | 33.31% | 87.13% | 41.77% | 57.5% | 16.64% | -74.1% | -308.74% | -114.26% | -213.99% |
| Net Income | -5.41M | 40.75M | -6.47M | -24.46M | -9.74M | -9.22M | -12.09M | -9.75M | -11.03M | -8.41M | -8.56M | -6.5M | -6.54M | -5.83M | -7.72M | -6.84M | -6.9M | -9.67M | -9.46M | -6.66M |
| Depreciation & Amortization | 52K | -28K | 0 | 0 | 0 | 0 | -24K | 24K | 34K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | -6.59M | 2.98M | 1.53M | 2.08M | 1.76M | 1.72M | 2.35M | 1.78M | 1.88M | 1.89M | 1.86M | 1.74M | 1.79M | 1.94M | 1.89M | 1.54M | 1.52M | 1.61M | 769K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.41M | -36.03M | -598K | 16.51M | 0 | 6K | 39K | 0 | 0 | 45K | 54K | 58K | 67K | 68K | 147K | 57K | 56K | 57K | 53K | 16K |
| Working Capital Changes | 546K | -1.05M | -1.35M | -965K | 839K | -3.56M | 3.37M | -514K | 1.74M | 3.08M | 2.36M | 1.41M | 3.59M | -1.72M | 2.27M | 136K | -3.55M | -1.69M | -124K | 161K |
| Change in Receivables | 3.77M | -2.08M | -309K | -739K | -7K | 11K | 1.99M | -723K | -248K | -179K | -217K | 164K | 6.25M | -3.93M | 529K | 588K | -144K | -358K | -2.03M | -775K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -164K | -6.25M | 0 | -529K | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -3.02M | 893K | -329K | 554K | 737K | -4.08M | 1.22M | 71K | 1.41M | 4.18M | 1.36M | 308K | -3.13M | 1.74M | 1.78M | -864K | -1.25M | -418K | 1.86M | 788K |
| Cash from Investing | 0 | -143K | -193K | -706K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15M |
| Capital Expenditures | 0 | -706K | -193K | -706K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15M |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 563K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 67K | 0 | 22.27M | 5.27M | -2.08M | 9.79M | 13M | -2.5M | -2.5M | -1.73M | 0 | 0 | 0 | 0 | 0 | 729K | 0 | 52.94M | 14.95M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | -2.5M | -2.5M | -2.5M | -2.5M | -2.5M | -2.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14.95M |
| Equity Issued (Net) | 0 | 67K | 0 | 22.27M | 5.27M | 0 | 12.29M | 15.5M | 0 | 0 | 775K | 0 | 0 | 0 | 0 | 0 | 699K | 0 | 51.81M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 1K | 422K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30K | 0 | 1.14M | 0 |
| Net Change in Cash | -3.39M | -2.98M | -5.64M | 14.04M | -1.58M | -12.63M | 2.48M | 5.07M | -9.85M | -5.96M | -6.01M | -3.18M | -1.15M | -5.25M | -3.81M | -5.52M | -8.08M | -9.66M | 44.95M | -5.82M |
| Free Cash Flow | -3.4M | -3.66M | -5.63M | -8.08M | -6.82M | -11.01M | -6.99M | -7.89M | -7.48M | -3.4M | -4.26M | -3.17M | -1.14M | -5.7M | -3.37M | -4.76M | -8.87M | -9.78M | -7.92M | -5.71M |
| FCF Margin % | - | - | - | - | -13648% | - | - | - | -53400% | -12146.43% | -9916.28% | -6900% | -3002.63% | -5871.13% | -3435.71% | -29743.75% | -5438.65% | -6000% | -56592.86% | - |
| FCF Growth % | 50.13% | 66.76% | 19.38% | -2.47% | 8.72% | -223.82% | -63.84% | -148.46% | -555.21% | 40.28% | -26.64% | 33.31% | 87.13% | 41.77% | 57.5% | 16.64% | -74.1% | -308.74% | -114.26% | -213.99% |
| FCF per Share | -0.13 | -0.14 | -0.21 | -0.35 | -0.30 | -0.49 | -0.35 | -0.41 | -0.41 | -0.19 | -0.24 | -0.18 | -0.06 | -0.32 | -0.19 | -0.27 | -0.50 | -0.56 | -0.46 | -0.38 |
| FCF Conversion (FCF/Net Income) | 0.63x | 0.56x | 0.84x | 0.30x | 0.70x | 1.19x | 0.58x | 0.81x | 0.68x | 0.40x | 0.50x | 0.49x | 0.17x | 0.98x | 0.44x | 0.70x | 1.28x | 1.01x | 0.84x | 0.86x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 1.03M | 0 | 0 | 0 | 384K | 464K | 0 | 0 | 410K | 0 | 310K | 291K | 294K | 265K | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |